Antibody-Drug Conjugates: Advancing Ovarian Cancer Treatment
Ovarian cancer, a common malignancy among women, is often treated using antibody-drug conjugates (ADCs), a targeted therapy approach. ADCs combine an antibody that binds to a specific antigen on cancer cells with a cytotoxic payload, delivering it directly to the tumor. The advancement of ADCs in ovarian cancer has improved treatment efficacy and reduced side…